I don't think I'll add much to this other than to emphasize that yes, medical device regulation is a particular challenge for a number of reasons.
It would strike me that one of the questions to ask might actually be the extent to which Canada is collaborating with regulatory agencies abroad on device regulation. I know that our regulatory agencies have meetings of what they call the heads of agencies network.
It would seem to me that this would be the kind of topic they should be discussing at an international level, in part because the science undermining devices or medicines isn't just brought to bear to Canada, but is brought to all sorts of markets comparable to us. We basically struggle with very similar problems in different countries. We probably could learn what they might call regulatory innovations from other countries.